Related Experiment Video
Updated: Aug 14, 2025
Protein Transfection of Mouse Lung
Published on: May 15, 2013
The Biology and Function of Tissue Inhibitor of Metalloproteinase 2 in the Lungs
Louis Costanzo1, Brian Soto1, Richard Meier1
1Department of Medicine, State University of New York Downstate Health Sciences University, 450 Clarkson Avenue, Brooklyn, NY 11203, USA.
Abstract:
Tissue inhibitors of matrix metalloproteinases (TIMP) are a family of four endogenous proteins that primarily function to inhibit the activities of proteases such as the matrix metalloproteinases (MMP). Altered MMP/TIMP ratios are frequently observed in several human diseases. During aging and disease progression, the extracellular matrix (ECM) undergoes structural changes in which elastin and collagens serve an essential role. MMPs and TIMPs significantly influence the ECM. Classically, elevated levels of TIMPs are suggested to result in ECM accumulation leading to fibrosis, whereas loss of TIMP responses leads to enhanced matrix proteolysis. Here, we outline the known roles of the most abundant TIMP, TIMP2, in pulmonary diseases but also discuss future perspectives in TIMP2 research that could impact the lungs. TIMP2 directly inhibits MMPs, in particular MMP2, but TIMP2 is also required for the activation of MMP2 through its interaction with MMP14. The protease and antiprotease imbalance of MMPs and TIMPs are extensively studied in diseases but recent discoveries suggest that TIMPs, specifically, TIMP2 could play other roles in aging and inflammation processes.
Insights
Tissue inhibitors of matrix metalloproteinases (TIMPs), particularly TIMP2, play crucial roles in lung diseases by regulating matrix metalloproteinases (MMPs). Research highlights TIMP2
Area of Science:
- Biochemistry
- Cell Biology
- Pulmonology
Background:
- Tissue inhibitors of matrix metalloproteinases (TIMPs) are endogenous proteins that regulate matrix metalloproteinase (MMP) activity.
- Imbalances in MMP/TIMP ratios are implicated in various human diseases, affecting extracellular matrix (ECM) structure during aging and disease.
- TIMPs influence ECM remodeling, with elevated levels potentially causing fibrosis and reduced levels leading to excessive matrix proteolysis.
Purpose of the Study:
- To outline the established roles of TIMP2, the most abundant TIMP, in pulmonary diseases.
- To explore future research directions for TIMP2's impact on lung health and disease.
- To discuss emerging evidence suggesting TIMP2's involvement in aging and inflammation beyond its antiprotease functions.
Main Methods:
- Review of existing literature on TIMP2 function in pulmonary diseases.
- Analysis of TIMP2's direct inhibition of MMPs, including MMP2.
- Examination of TIMP2's role in MMP2 activation via MMP14 interaction.
Main Results:
- TIMP2 directly inhibits MMPs, notably MMP2.
- TIMP2 is essential for MMP2 activation, interacting with MMP14.
- Altered MMP/TIMP balance is a hallmark of many diseases.
Conclusions:
- TIMP2 is a key regulator of MMP activity in the context of lung diseases.
- Beyond its canonical inhibitory role, TIMP2 has complex functions in ECM regulation.
- Further investigation into TIMP2's roles in aging and inflammation is warranted for potential therapeutic strategies in lung diseases.
Related Concept Videos
01:23Role of Matrix Metalloproteases in Degradation of ECM
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
01:16TGF - β Signaling Pathway
02:17The Tumor Microenvironment
01:28Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...